VOLTFAST 50 mg granulato per soluzione orale, VYDURA 75 mg oral lyophilisate clinical trials

A Randomized, Parallel-Group, Single-Attack, Open-Label Study to Evaluate the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine (ATOM).

This study is looking at how well two different medicines, Voltfast and Vydura, work to stop a migraine attack. Researchers want to see how many people are completely free of pain two hours after taking their medicine, and if they need other pain relief.